PMID: 16515766Mar 7, 2006Paper

Osteoprotegerin as a potential therapy for osteoporosis

Current Rheumatology Reports
Neveen A T Hamdy

Abstract

The discovery and characterization of the RANKL/RANK/OPG signaling pathway and the identification of its role in the pathogenesis of bone loss have provided the rationale for the development of drugs with the ability to modulate RANK-induced osteoclastogenesis. In vivo studies have identified interfering with the RANKL/RANK interaction as a potential therapeutic target in the management of osteoporosis. Two agents capable of blocking the binding of RANKL to RANK have been so far tested in clinical studies--osteoprotegerin (Fc-OPG fusion molecule) and the RANKL-antibody (AMG 162). Both have been found to have profound inhibitory effects on bone resorption, with AMG 162 appearing to be overall superior to OPG. Data are still very scarce, however, and much remains to be uncovered before novel strategies capable of modulating the RANKL/OPG signaling pathway could be safely and effectively used in the management of osteoporosis.

References

Aug 1, 1996·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·R Pacifici
May 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·H YasudaT Suda
Jun 11, 1998·The Journal of Biological Chemistry·J G EmeryP R Young
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·H HsuW J Boyle
Mar 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·J LiW J Boyle
Jun 28, 2000·Proceedings of the National Academy of Sciences of the United States of America·N K ShevdeJ W Pike
Sep 1, 2000·Science·S L Teitelbaum
Oct 12, 2000·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Y KobayashiH Sakai
Feb 24, 2001·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·P J BekkerC R Dunstan
Mar 10, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·N SasakiY Asano
Nov 14, 2001·Reviews in Endocrine & Metabolic Disorders·L T Duong, G A Rodan
Nov 20, 2001·Endocrinology·S Khosla
Jun 7, 2002·Endocrine Reviews·B Lawrence RiggsL Joseph Melton
Aug 31, 2002·Endocrine Reviews·Ann CranneyUNKNOWN Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group
Dec 5, 2002·The Journal of Clinical Investigation·M Neale WeitzmannRoberto Pacifici
Dec 20, 2002·Proceedings of the National Academy of Sciences of the United States of America·Gianluca ToraldoM Neale Weitzmann
Apr 17, 2003·The Journal of Clinical Investigation·Guitty Eghbali-FatourechiB Lawrence Riggs
May 16, 2003·Nature·William J BoyleDavid L Lacey
Sep 13, 2003·The Journal of Clinical Endocrinology and Metabolism·Volker ViereckLorenz C Hofbauer
Oct 14, 2003·International Journal of Toxicology·Brenda B SmithHarold Davis
Jan 14, 2004·The Journal of Pharmacology and Experimental Therapeutics·Jude E OnyiaT John Martin
Feb 3, 2004·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Beiqing PanAndrew C W Zannettino
Mar 5, 2004·JAMA : the Journal of the American Medical Association·Georg SchettJohann Willeit
May 4, 2004·Nature Medicine·Roland Baron
Jun 5, 2004·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Pirow J BekkerAlex M DePaoli
Jul 29, 2004·JAMA : the Journal of the American Medical Association·Lorenz C Hofbauer, Michael Schoppet
Feb 16, 2005·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Pedro Mezquita-RayaManuel Muñoz-Torres
Mar 5, 2005·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Sutharshani SivagurunathanRebecca S Mason

❮ Previous
Next ❯

Citations

Nov 25, 2006·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·K HenriksenM A Karsdal
Sep 15, 2009·Cancer Cell International·Sofia FiliBernhard Schaller
Jul 24, 2007·The Journal of Urology·Deborah A BradleyPhilip Kantoff
Jun 30, 2011·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Julie RousseauValérie Trichet
Feb 4, 2016·Revista da Associação Médica Brasileira·Gisela Rodrigues da Silva SassoEdmund Chada Baracat
Jul 1, 2007·Current Opinion in HIV and AIDS·Nicholas S ChewWilliam G Powderly
Aug 28, 2018·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·Marta Martín-FernándezConcepción De la Piedra

❮ Previous
Next ❯

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Clinical Investigation
Guitty Eghbali-FatourechiB Lawrence Riggs
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
P J BekkerColin R Dunstan
The New England Journal of Medicine
G David Roodman
© 2021 Meta ULC. All rights reserved